Fischer Medical Ventures Ltd — Updates, 09-04-2025: Company Update

Fischer Medical Ventures Limited has announced a board meeting to discuss the activation of International Securities Identification Number (ISIN) INE771F13020 for fully convertible warrants allocated on 18th February 2025. This activation reflects the company's strategic move towards enhancing shareholder value and improving investment appeal. The issuance of these convertible warrants can potentially alleviate capital needs and provide new funding avenues, leading to operational growth. Investor sentiment may see a positive outlook as this move suggests proactive management in leveraging financial mechanisms for expansion.